about
Danger signals, inflammasomes, and the intricate intracellular lives of chlamydiaeCellular mechanisms of tissue fibrosis. 6. Purinergic signaling and response in fibroblasts and tissue fibrosisPurinergic signalling during sterile liver injury.Autoimmune Hepatitis: Clinical Review with Insights into the Purinergic Mechanism of DiseaseLipoapoptosis induced by saturated free fatty acids stimulates monocyte migration: a novel role for Pannexin1 in liver cells.Sterile inflammation in hepatic ischemia/reperfusion injury: present concepts and potential therapeutics.Adenosine A1 modulators: a patent update (2008 to present).Purinergic signalling in the liver in health and disease.Unlocking the Potential of Purinergic Signaling in TransplantationExpression of mediators of purinergic signaling in human liver cell lines.The P2X4 purinergic receptor impacts liver regeneration after partial hepatectomy in mice through the regulation of biliary homeostasis.Diphenyl diselenide modulates nucleotidases, reducing inflammatory responses in the liver of Toxoplasma gondii-infected mice.Hepatic and seric levels of purines in rats experimentally infected by Fasciola hepatica.Proliferation of mouse liver stem/progenitor cells induced by plasma from patients with acute liver failure is modulated by P2Y2 receptor-mediated JNK activation.Multifaceted Effects of Extracellular Adenosine Triphosphate and Adenosine in the Tumor-Host Interaction and Therapeutic Perspectives.Characterization of E-NTPDase (EC 3.6.1.5) activity in hepatic lymphocytes: A different activity profile from peripheral lymphocytes.The P2X7 Receptor in Inflammatory Diseases: Angel or Demon?CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury.
P2860
Q28076278-74EBA6CA-5F6F-4D72-ACF9-CE0266D7C910Q33569405-2833E4E6-F470-4F87-8B96-CE8F686D4D13Q34035530-A2591302-3B50-41F4-9712-43963EBBF3C5Q35906055-6B46D95E-8242-40DE-A0F4-7BC40EED3489Q35930758-54D4F1C4-A370-44A2-A3EF-0CD339C7266CQ38065291-7C28D3C8-9BAD-4906-BE43-B2EC487CEACAQ38109907-E0488CB0-96C1-4CB8-83A9-35812FE02B5BQ38165746-56C1B852-4F0D-45A8-A738-0DB881DC5EA0Q38785475-A377855C-5195-4A8D-8866-84AACD5F6CF6Q38959199-A3B19AA0-EEEE-407E-BA17-E29279D96006Q39683781-66624637-58D0-4790-8D8A-5E2557E9D905Q40090584-2F5225FA-9FC8-496D-AA69-7AEA4DF298FAQ40757797-58ECE019-6342-43C4-B21F-07732AF4463AQ44487620-883346D5-A1D3-4A10-8707-0C517FFC0B56Q46026307-F13F091A-7F57-4502-A53E-6C6593672995Q46255083-EB544AF5-63D9-47CD-B702-096C904406F5Q50202418-86F57046-4C1A-4468-8419-D866EAFDC811Q52768241-7F4AC80E-F25F-4A86-B327-25EC2AA2DF83
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Pathological roles of purinergic signaling in the liver
@en
type
label
Pathological roles of purinergic signaling in the liver
@en
prefLabel
Pathological roles of purinergic signaling in the liver
@en
P2860
P1476
Pathological roles of purinergic signaling in the liver
@en
P2093
Geoffrey Burnstock
Simon C Robson
P2860
P304
P356
10.1016/J.JHEP.2012.06.008
P577
2012-06-16T00:00:00Z